Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Huakebi is a brand name for a compound paracetamol and amantadine hydrochloride capsule, a common over-the-counter (OTC) medication in China used to treat symptoms of the common cold and influenza. Developed and manufactured by Shandong Chenxin Pharmaceutical (SCCPC), the combination typically includes paracetamol for pain and fever relief, amantadine hydrochloride as an antiviral agent against influenza A, chlorpheniramine maleate to reduce allergic symptoms like runny nose and sneezing, caffeine to counteract the sedative effects of the antihistamine, and artificial bezoar for its traditional antipyretic and sedative properties.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on compound paracetamol and amantadine hydrochloride.